Navigation Links
Renowned Scientists Join Cure Alzheimer’s Fund’s Search for Alzheimer’s Therapies
Date:11/19/2013

Boston, MA (PRWEB) November 19, 2013

Adding to its impressive roster of many of the nation’s leading scientists, the Cure Alzheimer’s Fund Research Consortium is pleased to announce its two newest members, Eric Schadt, Ph.D., and Rick Huganir, Ph.D.

The Research Consortium develops and updates a "roadmap for research" for the most effective and efficient route to slowing, stopping and/or reversing Alzheimer’s disease, the most common form of dementia. Members research their own projects and recruit others whose work will hasten the development of effective therapies.

"We are very excited about the prospect of working with these two truly outstanding scientists in our quest to conquer Alzheimer’s disease," said Dr. Rudolph E. Tanzi, consortium chair and director of the Genetics and Aging Research Unit at Harvard Medical School.

Eric Schadt, Ph.D., is director of the Icahn Institute for Genomics and Multiscale Biology and chair of the Department of Genetics and Genomics Sciences. He is also a professor of genomics at the Icahn School of Medicine at Mount Sinai.

Dr. Schadt is an expert in generating and integrating large-scale sequence variation, molecular profiling and using clinical data from disease populations to construct molecular networks that define disease states and link molecular biology to physiology. Dr. Schadt’s research has provided key insights into what is needed to master large-scale, diverse data collection to better understand diseases and to improve treatment options. He has published more than 200 peer-reviewed papers in leading scientific journals, and contributed to a number of discoveries related to the genetic basis of such common human disorders as diabetes, obesity and Alzheimer’s disease.

Richard L. Huganir, Ph.D., is a professor and director of the Solomon H. Snyder Department of Neuroscience and an investigator with Howard Hughes Medical Institute.

Dr. Huganir’s groundbreaking research on the mechanisms of communication between neurons in the brain earned him great recognition in the neuroscience community. He also has received the Young Investigator Award and the Julius Axelrod Award from the Society for Neuroscience. He has published more than 200 papers in peer-reviewed journals.

Cure Alzheimer’s Fund is governed by a board of directors, administered by a small, full-time staff and guided scientifically by a Research Consortium and Scientific Advisory Board. Cure Alzheimer’s Fund™ is a 501(c)(3) public charity. The fund has supported 77 projects in 51 laboratories of leading Alzheimer’s researchers in the United States and abroad.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11344632.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Renowned Dermatology Practice in San Diego Announces Launch of New Liposuction Website
2. As a Renowned Cosmetic Surgeon in Southern California, Dr. Kathy Gohar Introduces New Anti-Aging Procedures
3. Cheap Ball Gown Wedding Dresses Offered By The Renowned Dress Manufacturer, OgotoShop.com
4. Renowned Pro Boxer Tracy Patterson to Provide Expert Boxing Training Commentary in Art of Boxing Magazine
5. Renowned Woodland Hills Dentist Announces Open Slots for Complimentary Consultations
6. Renowned Creighton University Professor Named President-Elect of the American Society of Bioethics and Humanities
7. Renowned Dentist from Around The Corner Dental Health Spa Unveils Why His Office in Woodlands Hills is the Best Choice for Dental Implants
8. Reputed and Renowned Ecommerce Expert, Shopping Cart Elite Proclaims New Features to Their Website
9. Renowned Digestive Health Expert, Brenda Watson, Returns to Public Television with 2 Eye-Opening Specials
10. World-Renowned Autism Expert Dr. Doreen Granpeesheh Presents Keynote Address at CARD Louisiana Autism Conference, August 24th in Baton Rouge
11. Renowned Shopping Cart Software Expert Shopping Cart Elite Officially Declares The Launch Of Mimousa.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... the latest in wound care advancements to physician colleagues, skilled nursing facility medical ... titled, "Navigating the Treacherous Waters of Wound Care." , "At many of these ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: